Vanda Pharmaceuticals Inc. (VNDA)
$5.29-$0.15 (-2.76%) Today
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 7 | 329,600 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
23 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel Patrick McGuire - Officer | Grant or award | Common Stock | 80,000 | $0.00 | - | |
 Phaedra Chrousos | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Charles Cliff Duncan | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Richard W. Dugan | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Anne Sempowski Ward | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Tage Honore | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Stephen Ray Mitchell | Grant or award | Common Stock | 41,600 | $0.00 | - | |
| Stephen Ray Mitchell | Gift | Common Stock | 25,836 | $0.00 | - | |
| Charles Cliff Duncan | Grant or award | Common Stock | 57,101 | $0.00 | - | |
| Timothy Williams - Officer | Open-market sale | Common Stock | 42,434 | $8.27 | $351K | |
| Kevin Patrick Moran - Officer | Open-market sale | Common Stock | 42,442 | $8.27 | $351K | |
| Joakim Wijkstrom - Officer | Open-market sale | Common Stock | 30,800 | $8.27 | $255K | |
| Mihael Hristos Polymeropoulos - Officer | Open-market sale | Common Stock | 156,235 | $8.17 | $1.28M | |
| Gunther Birznieks - Officer | Open-market sale | Common Stock | 42,431 | $8.27 | $351K | |
| Tage Honore | Open-market sale | Common Stock | 30,000 | $8.03 | $241K | |
| Joakim Wijkstrom - Officer | Grant or award | Common Stock | 125,000 | $0.00 | - | |
| Gunther Birznieks - Officer | Grant or award | Common Stock | 125,000 | $0.00 | - | |
| Timothy Williams - Officer | Grant or award | Common Stock | 125,000 | $0.00 | - | |
| Kevin Patrick Moran - Officer | Grant or award | Common Stock | 125,000 | $0.00 | - | |
| Mihael Hristos Polymeropoulos - Officer | Grant or award | Common Stock | 525,000 | $0.00 | - | |
| Mihael Hristos Polymeropoulos - Officer | Open-market purchase | Common Stock | 10,000 | $4.15 | $42K | |
| Richard W. Dugan | Grant or award | Common Stock | 59,225 | $0.00 | - | |
| Stephen Ray Mitchell | Open-market sale | Common Stock | 5,000 | $5.17 | $26K |
Vanda Pharmaceuticals Inc. (VNDA) had 7 insider filings in the last 90 days, with the most recent on 2026-06-08. The full record for VNDA runs to 23 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of VNDA were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of VNDA were filed in the last 90 days. 7 sales are on record for this company.
This page tracks VNDA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add VNDA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
